In this study, we show that patients with MIBC whose tumors have low STAG2 protein expression have improved OS and PFS, suggesting that the level of STAG2 expression may influence bladder cancer initiation or progression. This evidence concerns the gene STAG2 and urinary bladder carcinoma.